REGN vs SIEB · P/E 14, rev $14.34B vs rev $83.9M
Regeneron Pharmaceuticals Inc (REGN) versus Siebert Financial Corp (SIEB) — a side-by-side from cached financials, not a winner call.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Siebert Financial Corp (SIEB) is a capital markets company listed on US.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Latest reported SIEB revenue for 2024-12-31 was $83.9M. Net income was $13.3M. Revenue was up 17.3% from 2023-12-31 to 2024-12-31. SIEB currently screens at market cap $76.6M.
REGN currently screens at market cap $59.10B and trailing P/E 13.9. SIEB currently screens at market cap $76.6M.
Not investment advice. Open the REGN and SIEB stock pages for the full models.
Not investment advice.